QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 avid-bioservices-q2-eps-027-misses-012-estimate-sales-3350m-miss-3380m-estimate

Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(...

 rbc-capital-downgrades-avid-bioservices-to-sector-perform-raises-price-target-to-125

RBC Capital analyst Sean Dodge downgrades Avid Bioservices (NASDAQ:CDMO) from Outperform to Sector Perform and raises the pr...

 william-blair-reiterates-market-perform-on-avid-bioservices

William Blair analyst Max Smock reiterates Avid Bioservices (NASDAQ:CDMO) with a Market Perform.

 avid-bioservices-agrees-to-be-acquired-by-gho-capital-partners-and-ampersand-in-11b-transaction-shareholders-to-receive--1250-per-share-in-cash

The per share purchase price represents a 13.8% premium to Avid's closing share price of $10.98 on November 6, 2024, the la...

 rbc-capital-maintains-outperform-on-avid-bioservices-raises-price-target-to-12

RBC Capital analyst Sean Dodge maintains Avid Bioservices (NASDAQ:CDMO) with a Outperform and raises the price target from $...

 stephens--co-reiterates-overweight-on-avid-bioservices-maintains-12-price-target

Stephens & Co. analyst Jacob Johnson reiterates Avid Bioservices (NASDAQ:CDMO) with a Overweight and maintains $12 price...

 william-blair-reiterates-market-perform-on-avid-bioservices

William Blair analyst Max Smock reiterates Avid Bioservices (NASDAQ:CDMO) with a Market Perform.

 avid-bioservices-q1-2025-adj-eps-003-beats-006-estimate-sales-4017m-miss-4076m-estimate

Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0....

 why-avid-bioservices-stock-is-moving-higher-wednesday

Avid reported fourth quarter financial results on Tuesday after the market closed. The company reported a loss of $1.94 per sha...

 rbc-capital-reiterates-outperform-on-avid-bioservices-maintains-8-price-target

RBC Capital analyst Sean Dodge reiterates Avid Bioservices (NASDAQ:CDMO) with a Outperform and maintains $8 price target.

 avid-bioservices-q4-2024-gaap-eps-194-vs-004-estimate-sales-43000m-beat-42142m-estimate

Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(1.94) per share which missed the analyst consensus estimate of $(...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION